Mariner
MIRA icon

Mariner’s MIRA Pharmaceuticals MIRA Stock Holding History

Mariner’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7K Hold
16,500
– – ﹤0.01% 3497
2025
Q4 		$24.9K Hold
16,500
– – ﹤0.01% 3467
2025
Q3 		$22.4K Hold
16,500
– – ﹤0.01% 3507
2025
Q2 		$20K Buy
16,500
+5,000
+43% +$5.77K ﹤0.01% 3422
2025
Q1 		$11.3K Hold
11,500
– – ﹤0.01% 3405
2024
Q4 		$13.1K Buy
+11,500
New +$15K ﹤0.01% 3359

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Mariner's MIRA Position: Q1 2026 in Review

Mariner held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 16,500 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

Mariner first reported a position in MIRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $24.9K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Mariner held 16,500 shares of MIRA Pharmaceuticals worth $17.7K as of Q1 2026.
  • Mariner left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3497 holding.
  • Mariner first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Mariner's MIRA Pharmaceuticals position peaked at $24.9K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.